Single-Molecule All-In-One (SMALL) Dendritic Dots for Precise Cancer Theranostics

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Multifunctional nanoparticles are crucial for cancer theranostics.
• Current approaches often face challenges with structural precision due to stochastic functionalization.
• A single-component system is needed to overcome these limitations.

Purpose of the Study:

• To develop a universal, modular, and scalable design for single-molecule all-in-one (SMALL) dendritic dots (DDs).
• To create customizable theranostic platforms with well-defined functional architectures.
• To address the challenge of achieving multifunctionality with structural precision.

Main Methods:

• Dendrimer-based divergent synthesis using orthogonal protection, selective deprotection, and precise conjugation.
• Synthesis of perylenediimide (PDI)-cored and camptothecin-loaded polylysine dendrimer-based SMALL DDs.
• Characterization of DDs for structure, drug loading, particle size, fluorescence, and in vivo performance.

Main Results:

• Successfully synthesized SMALL DDs with precise structure, tunable drug loading, and stable fluorescence.
• Demonstrated long blood circulation, enhanced tumor accumulation, and enzyme-responsive drug release.
• Achieved potent antitumor activity in mice with hepatocellular carcinoma.

Conclusions:

• The SMALL DD strategy offers a solution to the multifunctionality-precision dilemma in nanoparticle design.
• These dendritic dots integrate imaging probes, drugs, and targeting/responsive ligands into a single molecule.
• SMALL DDs show significant promise for advancing cancer theranostics.